About the JoinT Audit Program®

The Joint Audit Program program offers blinded, collaborative third-party supplier qualification audits and licensable audit reports.

Rx-360 facilitates collaboration on all types of third-party audits between pharmaceutical manufacturers, suppliers, distributors, and third-party logistics providers. Our team handles the entire process through to management and closure of corrective and preventive actions.

The audit licensing program is a unique way to protect patient safety effectively and efficiently.

Learn More

about the Consortium

The Consortium is a network of professionals working in pharmaceutical and healthcare supply chain and quality departments all around the world.

Members get discounts and credits when using the Joint Audit Program and drive working groups that produce tools and resources to support their peers throughout the industry. Additional benefits include exclusive access to coworking and meeting spaces at our Philadelphia HQ and unlimited premium subscriptions to Leucine’s FDA Tracker.

LEARN MORE

Our History

2008
Rx-360 Founded

In 2008 a meeting with pharmaceutical industry executives and Janet Woodcock, director of the U.S. Food & Drug Administration’s Center for Drug Evaluation & Research (CDER) at the time, was convened following the heparin contamination that year that was responsible for 81 deaths in the U.S.—an event that brought the issue of drug safety and supply-chain security to the forefront.

After this meeting, Rx-360 was formed.

“My company has made significant use of the joint audit program over the last few years. The continuous improvement initiatives by Rx-360 around the joint audit program have become very evident over the past 12 months. In addition, as a member of the consortium, we have been able to utilize the "audit credits" benefit generated from previously sponsored joint audits to significantly reduce our out-of-pocket cost of audits we have co-sponsored or licensed this year!”
Rob Smith, Supplier Quality Audit & Compliance
GSK
Rx-360 is like an active "neighborhood watch" group that focuses on keeping the supply of medical products safe for patients worldwide. I am thankful that my company and so many of our peer and supplier companies are committed to working together on Rx-360's supply chain security mission on behalf of our patients!
Eric Berg, Director of Quality Assurance
Amgen, Inc.
Rx-360 brings valuable networking and education opportunities to my organization that operates in over 100 locations around the world, deeply involved with supply chain integrity and regulatory compliance for inbound and outbound to manufacturing and direct to patient distribution. Especially, our employees who volunteer in some of Working Groups such as Africa GDP, Data Integrity, and Medical Device reap many benefits that help the with their own professional growth, but also being able to contribute to the company with fresh knowledge and best practices.
David Bang, CEO
JAS
Remote Auditing has become part of the norm for many suppliers within the pharmaceutical industry. Being able to maintain audit quality while simultaneously being aware of the ever changing landscape becomes more important every day. Rx-360, through their member initiatives surrounding remote auditing, have captured the viewpoint of the supplier and set the industry on a path of best practice in remote auditing.
Mike McKay, President/CEO
SQA Services, Inc.